Overview
Mammoth Biosciences builds CRISPR-based diagnostics and genome-editing tools leveraging novel Cas proteins. Tailored for modern biology and life science teams.
Key Highlights
- Cas14 and Casɸ enzymes enabling compact, efficient editing.
- Point-of-care diagnostics platforms using CRISPR detection.
- Partnerships with pharma and diagnostic developers.
Ideal For
- Diagnostics innovators building rapid CRISPR-based tests
- Researchers exploring next-gen genome editing proteins
- Investors tracking CRISPR platform companies
Quick Links
- Official site: mammoth.bio
- Add to BioDir collections to track updates and collaborators.
